Latest

neurophramacology

This shows a doctor looking at brain scans.

Brain Cancer Featured Neurology Neuroscience

·November 7, 2024·4 min read

Novel Vaccine Targets Deadly Brain Tumors with Precision

A novel vaccine can mobilize the immune system to precisely target and attack cancerous brain tumors, specifically gliomas, one of the deadliest brain tumor types. This groundbreaking work demonstrates that the body’s immune system can be directed to target proteins with cancer-driving mutations in tumors, marking a significant advance in immunotherapy.

Featured Neurology Neuroscience

·July 30, 2024·4 min read

GLP-1 Drug Slows Alzheimer’s Cognitive Decline

A recent study suggests that a GLP-1 drug, liraglutide, may protect the brains of people with mild Alzheimer’s disease, slowing cognitive decline by 18% over one year. This effect is likely due to the drug’s ability to reduce brain inflammation, improve insulin resistance, and lower the impact of Alzheimer’s biomarkers.

Featured Neurology Neuroscience

·March 9, 2023·4 min read

Transporting Antibodies Across the Blood–Brain Barrier to Treat Alzheimer’s Disease

Researchers have developed a new method that uses antibody fragments encapsulated in nanomicelles which can cross the blood-brain barrier and reduce levels of amyloid-beta in the brains of mouse models of Alzheimer's disease.

Featured Neuroscience Psychology

·August 24, 2022·4 min read

Psychedelics May Lessen Fear of Death and Dying, Similar to Feelings Reported by Those Who’ve Had Near Death Experiences

Both those who experienced a natural near-death experience and those who had a near-death experience while taking psychedelics report less fear of death and a lasting, spiritual positive experience.

Featured Neuroscience Open Neuroscience Articles Psychology

·March 31, 2022·4 min read

The Relationship Between Psychedelics and Consciousness

When beliefs change following psychedelic use in relation to mystical experiences, attributions of consciousness tend to increase.

Featured Neurology Neuroscience Open Neuroscience Articles

·April 9, 2020·3 min read

First in-human study of drug targeting brain inflammation supports further development

MW189, a small molecule drug candidate, blocks abnormal inflammation in the brain which contributes to injury and disease induced neurological impairments.